Details

Autor(en) / Beteiligte

• Bar-On, Yinon M
• Goldberg, Yair
• Mandel, Micha
• Bodenheimer, Omri
• Freedman, Laurence
• Kalkstein, Nir
• Mizrahi, Barak
• Alroy-Preis, Sharon
• Ash, Nachman
• Milo, Ron
• Huppert, Amit

Titel

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Ist Teil von

• The New England journal of medicine, 2021-10, Vol.385 (15), p.1393-1400

Ort / Verlag

Boston: Massachusetts Medical Society

Erscheinungsjahr

2021

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Since July 30, 2021, more than a million fully vaccinated Israeli residents who were 60 years of age or older have received a third dose of the BNT162b2 mRNA vaccine. As of August 31, the rate of confirmed Covid-19 infection was lower in the booster group than in the nonbooster group by a factor of 11.3, and the rate of severe illness was lower by a factor of 19.5.